Rare diseases
Investigational molecules
Locations
Batiment B Epfl Innovation Park, 1015
The sponsor demonstrates a concentrated focus on developing therapeutic interventions for progressive neurodegenerative disorders. Research efforts are directed toward understanding and treating conditions characterized by cognitive decline and neuronal degeneration, with particular emphasis on diseases affecting memory and executive function in aging populations.
The organization invests in novel approaches targeting the underlying pathological mechanisms of dementia and related cognitive disorders, exploring interventions that may modify disease progression.
AC Immune S.A. runs clinical trials in conditions such as Dementia Alzheimer's type, Parkinson's disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Spain
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
